Book an Appointment

Dr. PALLABIKA MANDAL (ONCOLOGY TEAM)

MBBS, MS (Gen Surgery), MCh (Surgical Oncology - AIIMS, New Delhi)

Clinic Time
Day Time
MON 03:00 PM - 05:00 PM
TUE 09:00 AM - 11:00 AM
WED 03:00 PM - 05:00 PM
THU 09:00 AM - 11:00 AM
FRI 03:00 PM - 05:00 PM
SAT 09:00 AM - 11:00 AM
Areas Of Interest: Malignancies ofEsophagus, Upper gastrointestinal tract, Hepatobiliary region, Pancreas and Lung Research Work / Publications : Multicentric trials and research work 1. Opportunistic screening for common malignancies in the Northeast India at a tertiary healthcare facility: prospective database for cancer screening OPD. 2. To establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative research in the field of drug and device development, funded by BIRAC DBT) - Project ongoing. Multicentric project led by Tata Memorial Hospital, Mumbai. 3. Neoadjuvant chemotherapy followed by Surgery versus Surgery followed by adjuvant chemotherapy for resectable Gastric Adenocarcinoma-Phase 3 Multicentric Randomized Controlled trial (NAGA study) under Department of Health Research. Multicentric RCT led by JIPMER, Puducherry. 4. 4. Breast Cancer Survival Studies? a multicentric implementation research trial under ICMR 5. Publications: Mandal, P., Mishra, A., Deo, S.V.S. et al. A Pilot Study Evaluating Sentinel Lymph Node Biopsy Using Dual Dye Technique with ICG and Methylene Blue for Early Breast Carcinoma (EBC). Indian J Surg (2021). https://doi.org/10.1007/s12262-021-03124-2 Harris, C., Debnath, S., Mandal, P. et al. Short-term Outcomes of Treatment for Gynecological Cancers in a Tertiary Center in Northeast India. Indian J GynecolOncolog 21, 63 (2023) https://doi.org/10.1007/s40944-023-00743-3 Ray MD, Mandal P, Mishra A, Gupta N. Complex and Challenging Surgery like CRS with HIPEC is Feasible Midst the COVID 19 Pandemic: Experience from Tertiary Care Center in India. Indian J Gynecol Oncol. 2021;19(4):66. DOI: www.doi.org/10.1007/s40944-021-00558-0 Ray MD, Mandal P. Unusually elevated CA19.9 with adnexal mass: Does it lead to some conclusions or confusion? J Clin Images Med Case Rep. 2022; 3(9): 2067. DOI: www.doi.org/10.52768/2766-7820/2067